Medpace Holdings Inc vs Cloudflare Inc — how do they compare? Medpace Holdings Inc trades at $519.93 (market cap $15.08B), while Cloudflare Inc trades at $270.8 (market cap $96.69B). The key difference: Cloudflare Inc is far larger — about 6.4× Medpace Holdings Inc's market cap, and Cloudflare Inc is trading nearer its 52-week high, Medpace Holdings Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | NET | |
|---|---|---|
Market Cap | $15.08B | $96.69B |
Sector | Technology | Technology |
52-Week High | $620.59 | $281.69 |
52-Week Low | $308.88 | $160.16 |
Enterprise Value | $14.55B | $96.05B |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Cloudflare (NET) trades at $275.19, down 0.87% on the day, as the stock consolidates near recent highs. The company continues to demonstrate strong revenue growth with Q1 2026 earnings beating expectations, though it remains unprofitable with a -3.72% net margin. Technical indicators show a bullish trend with the stock trading above key support levels, while analyst sentiment remains positive with 72.5% recommending Buy. Recent product launches including Precursor behavioral defense highlight ongoing innovation in cybersecurity.
Outlook remains cautiously optimistic as Cloudflare leverages AI-driven cybersecurity demand, though profitability concerns and high valuations (P/S 41.75) present risks. The stock trades below consensus price target of $265.07, suggesting potential upside if execution continues. Key risks include intense competition and the company's ability to achieve sustainable profitability amid significant infrastructure investments.
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →